social-media-550766_640

Pharmafocus wants to hear from you!

pharmafile | July 17, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical 

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new feature that focuses on you, the reader. Many of you work on the front lines of pharma and life sciences, affected by the issues that we report on every day.

Your insight is invaluable, and we want to hear your experiences and viewpoints on the latest developments and trends as they emerge.

Disagree with the latest drug approval decision? Maybe you, your family, or a patient are affected? Excited about the prospect of a promising set of new research findings? Or even want to discuss a topic as a feature in our regular ‘Opinion’ column? Whether it’s a throwaway observation or extended commentary, we want to hear what you have to say.

Advertisement

Get in touch with us at editorial@pharmafile.com or direct message us on Twitter and share your comments and thoughts – the best could even make it into the upcoming issue.

Related Content

ProBioGen secures extended GMP authorisation for viral manufacturing facility

ProBioGen has secured extended manufacturing authorisation and an updated Good Manufacturing Practice (GMP) certificate for …

Envirogen secures place on NHS Scotland reverse osmosis framework

Envirogen has been appointed to Lot 6, covering reverse osmosis (RO), of the national Decontamination …

Amphista doses first patient in AML trial of protein degrader

Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an …

The Gateway to Local Adoption Series

Latest content